MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$4,149K
(17.80%↑ Y/Y)
Accretion (amortization)
of investments
$2,479K
(-29.31%↓ Y/Y)
Change in fair value of
short-term investment ...
$432K
(189.07%↑ Y/Y)
Other income, net
$148K
(260.98%↑ Y/Y)
Net loss
attributable to common...
-$201,142K
(-2.69%↓ Y/Y)
Total other income,
net
$7,208K
(9.46%↑ Y/Y)
Related Party
$4,586K
Nonrelated Party
$46K
Loss from operations
-$208,350K
(-2.91%↓ Y/Y)
Collaboration revenue
$4,632K
(187.88%↑ Y/Y)
Total operating
expenses
$212,982K
(3.67%↑ Y/Y)
Research and development
$160,636K
(3.44%↑ Y/Y)
General and
administrative
$52,346K
(4.36%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME)